EXHIBIT 32.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Enox Biopharma, Inc. (the "Company")
on Form 10-Q for the period ended September 30, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Prof.
Yossef Av-Gay, principal executive officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:

     (1)  the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


Date: November 16, 2009               By: /s/ Prof. Yossef Av-Gay
                                         ------------------------------------
                                      Name:  Prof. Yossef Av-Gay
                                      Title: President
                                             (Principal Executive Officer)